Sangeetha Venugopal

13PUBLICATIONS
37CO-AUTHORS
Medical microbiology not elsewhere classifiedMolecular medicineHaematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 22, 2026
Not guilty by association: myelodysplasia-related mutations in AML.

|Mar 13, 2025
Azacitidine and venetoclax for HR-MDS: election results pending.

Sangeetha Venugopal, Mikkael A Sekeres

|Oct 25, 2024
Drug development in higher-risk myelodysplastic syndromes.

Sangeetha Venugopal, Mikkael A Sekeres

|Feb 01, 2024
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax.

Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li

|Jul 20, 2023
Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress.

Sangeetha Venugopal, Rory M Shallis, Amer M Zeidan

|May 17, 2023
Olutasidenib: from bench to bedside.

Sangeetha Venugopal, Justin Watts

Pageof 3

Frequent Collaborators

6 joint publications

Naval G Daver

6 joint publications

Tapan M Kadia

5 joint publications

Courtney D DiNardo

4 joint publications

Guillermo Montalban-Bravo